{
  "docId": "019de071-dcb4-71ce-82aa-3fde96763369",
  "docSlug": "c85401f3daf1ffc5cb0e20a3335252d7",
  "documentTitle": "BenevolentAI | SPAC Presentation Deck | 42 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 17,
  "pageCount": 42,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide uses a process flow diagram to map specific technical capabilities to stages of drug discovery.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-dcb4-71ce-82aa-3fde96763369/17",
  "deckHref": "/decks/019de071-dcb4-71ce-82aa-3fde96763369",
  "deckJsonHref": "/decks/019de071-dcb4-71ce-82aa-3fde96763369.json",
  "deckAnchorHref": "/decks/019de071-dcb4-71ce-82aa-3fde96763369#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.715
      },
      "kind": "diagram",
      "text": "Target ID, Hit Identification, Hit Expansion, Lead Optimisation, Candidate Seeking",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "69eb51fc-f70e-4cf5-90e6-dc7984cc3471",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.9,
        "x": 0.05,
        "y": 0.6
      },
      "kind": "list",
      "text": "Druggability scoring to prioritise targets; Binding site comparison to identify Hit matter and evaluate selectivity; Proprietary pharmacophore building methodology; ML models of activity and ADMET endpoints; Binding site detection to identify differentiating chemistry opportunities; Customisable virtual screening pipeline now on >10 billion compound scale; Protein-Ligand interaction mining to surface protein-centric bioisosteres; Programme visualisation",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a390a33-0c50-4bac-b520-07f39e48e478",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.9,
        "x": 0.05,
        "y": 0.3
      },
      "kind": "list",
      "text": "Highly experienced drug discovery team with a proven track record of taking nascent programme ideas and delivering drugs to the clinic\nChemoinformatic and AI tools impacting all stages of a drug programme from target selection through to candidate nomination\nEmpowering chemists to design better drugs in fewer cycles – candidate drugs delivered in as little as 2 years from programme inception compared to 3-5 year industry standard",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b3f10929-2869-4086-ba9b-d2993740715f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "We combine deep expertise in drug discovery with innovative techniques in structure-based design, virtual screening and machine learning.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ecd86612-5775-4030-9605-070cce4257da",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Molecular Design — Expertise in structure-based design, virtual screening and machine learning",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b26e44e8-3fa0-4b76-8d90-9d1bc9108d54",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "995a2a9c-f8c7-465a-99ca-d6c2351c2154",
      "evidence": "list/bullet: Druggability scoring to prioritise targets; Binding site comparison to identify Hit matter and evaluate selectivity; Proprietary pharmacophore building methodology; ML models of activity and ADMET endpoints;",
      "confidence": 0.5
    }
  ],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "428097d4-3994-495b-bb8a-b8ac31b75f15",
      "evidence": "The slide maps technical capabilities to a linear drug discovery pipeline.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}